The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 10 rounds in the feed, most often at Series B and in Biotech.
Venture capitalamecloudventures.comRounds from 2014-02-17 to 2025-02-26
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Eikon Therapeutics Eikon is a late-stage clinical biopharmaceutical company focused on inventing and developing breakthrough therapeutics for serious illnesses through innovative scientific and engineering approaches. | Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $350.7M | 2025-02-26 | [ PART ] |
Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $75M |
| 2022-07-20 |
| [ PART ] |
Eikon Therapeutics Eikon is a late-stage clinical biopharmaceutical company focused on inventing and developing breakthrough therapeutics for serious illnesses through innovative scientific and engineering approaches. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $517.8M | 2022-01-06 | [ PART ] |
Astranis Astranis sells advanced geostationary (GEO) satellite systems that provide dedicated broadband connectivity and support government communications. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $250M | 2021-04-14 | [ PART ] |
BigHat Biosciences A clinical-stage, AI-driven protein therapeutics platform company | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $19M | 2021-02-10 | [ PART ] |
BigHat Biosciences A clinical-stage, AI-driven protein therapeutics platform company | Seed Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2019-10-22 | [ PART ] |
Mythic Mythic sells innovative AI chips designed for high energy efficiency and performance in various applications including automotive and robotics. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2019-06-12 | [ PART ] |
Mythic Mythic sells innovative AI chips designed for high energy efficiency and performance in various applications including automotive and robotics. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $40M | 2018-03-20 | [ PART ] |
Ripple Financial Infrastructure & Blockchain Technology Solutions | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $28M | 2015-05-19 | [ PART ] |
Eat Just Just Home sells plant-based food products, including alternatives to eggs, meat, protein, and condiments, primarily for health-conscious consumers and restaurants. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $23M | 2014-02-17 | [ PART ] |